Boundless Bio, Inc.
BOLD
$2.83
$0.061.98%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -64.01M | -55.99M | -58.20M | -61.76M | -64.39M |
| Total Depreciation and Amortization | 2.16M | 1.22M | 1.25M | 1.24M | 1.19M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.95M | 6.85M | 6.82M | 6.90M | 6.73M |
| Change in Net Operating Assets | -10.34M | 821.00K | 3.46M | 1.51M | 1.28M |
| Cash from Operations | -56.25M | -47.10M | -46.66M | -52.12M | -55.19M |
| Capital Expenditure | -485.00K | -495.00K | -546.00K | -588.00K | -1.06M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 61.59M | 49.82M | 38.35M | 27.24M | 39.36M |
| Cash from Investing | 61.11M | 49.33M | 37.80M | 26.65M | 38.31M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 97.00K | 141.00K | 141.00K | 230.00K | 230.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | -13.00K |
| Cash from Financing | 97.00K | 141.00K | 141.00K | 230.00K | 217.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.96M | 2.37M | -8.72M | -25.23M | -16.67M |